• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Rhythm Pharmaceuticals

edit

Rhythm is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases. Rhythm investors include MPM Capital and New Enterprise Associates. The company is based in Boston, Massachusetts.

Milestones

edit

• 
  Rhythm Pharmaceuticals added Keith M. Gottesdiener as CEO.
  Posted 11/9/11 at 8:16pm
• 
  Rhythm Pharmaceuticals added Elizabeth Stoner as Chief Development Officer & Founder.
  Posted 3/15/10 at 7:45pm
• 
  Rhythm Pharmaceuticals added Bart Henderson as President & Founder.
  Posted 3/15/10 at 7:45pm
• 
  Rhythm Pharmaceuticals received $19M in Series A funding. (9/8/10)
  Posted 9/13/10 at 1:01am via genengnews.com
• 
  Rhythm Pharmaceuticals received $21M in Series A funding. (3/15/10)
  Posted 3/15/10 at 7:45pm via fiercebiotech.com

Videos

Screenshots

edit

Sources

1. Rhythm Pharma raises $21M for metabolic diseases (fiercebiotech.com) [edit]
2. Rhythm Adds $19M to Series A Round to Advance Peptide-Based Drugs (genengnews.com) [edit]